Hypotriglyceridemic Action Of Omega-3 Fatty-Acids In Healthy-Subjects Does Not Occur By Enhanced Lipoprotein-Lipase And Hepatic Lipase Activities

Single blind administration of EPA-rich omega-3 fatty acids at 3 dose levels of 3g, 6g and 12g/d (each dose lasting 3 weeks was separated by 2 weeks on placebo) lowered plasma TG levels and lecithin cholesterol acyltransferase-molar esterification rate (LCAT-MER) activity (6.12g/d). Lipolytic enzymes activity (LPL and HL) remained unchanged at these doses. Fat malabsorption was unlikely because of unmodified plasma beta-carotene, retinol and alpha-tocopherol levels.